Results 111 to 120 of about 5,464 (192)

Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.

, 2003
BACKGROUND: Both stenting and the glycoprotein IIb/IIIa inhibitor abciximab improve outcomes for patients undergoing primary angioplasty for acute myocardial infarction (AMI). However, the cost-effectiveness of these strategies is unknown.
Bakhai, Ameet, Tcheng, James E, Cohen, David J, Griffin, John J, Murphy, Sabina A, Berezin, Ronna H, Stuckey, Thomas, Grines, Cindy L, Githiora, Louise, Cox, David A, Stone, Gregg W   +10 more
core  

Intracoronary adjunctive therapies for ST-elevation myocardial infarction: a network meta-analysis of trials. [PDF]

Eur Heart J Cardiovasc Pharmacother
Laborante R, Bianchini E, Ciliberti G, Paglianiti DA, Filomia S, Bianchini F, Galli M, Biondi-Zoccai G, Serruys PW, Crea F, Patti G, Savarese G, Trani C, Burzotta F, D'Amario D.   +14 more
europepmc   +1 more source

Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease. [PDF]

Curr Rheumatol Rep
Kocatürk B, Berberoğulları B, Aliyev E, Sağ E, Özen S, Arditi M.   +5 more
europepmc   +1 more source

Letter to the Editor regarding: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI". [PDF]

Cardiol J
Umińska JM.
europepmc   +1 more source

Trombocitopenia extrema secundaria a abciximab

, 2004
Los antiagregantes antiglucoproteína IIb/IIIa bloquean la unión del fibrinógeno y el factor de Von Willebrand a sus receptores. Pueden causar hemorragia y trombocitopenia.
Delgado Amaya, Manuel, Prieto Palomino, Miguel A., Aragonés Manzanares, R., Bullones Ramírez, Juan A., Arias García, Dolores M., Castillo Castro, José L.   +5 more
core  

Glycoprotein IIb/IIIa Blockade: Ready to CELEBRATE a New Dawn? [PDF]

Eur Cardiol
Cate-Hoek AJT, Rocca B.
europepmc   +1 more source

Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature. [PDF]

J Clin Med
Kosowski M, Kocjan M, Mazurkiewicz M, Gamrot-Wrzoł M, Ryl S, Nowakowski K, Kawecki J, Kukulski T, Kawecki D, Morawiec-Migas B.   +9 more
europepmc   +1 more source

Prophylactic tirofiban versus oral dual antiplatelet therapy in patients undergoing endovascular treatment of intracranial aneurysms: A meta-analysis. [PDF]

Medicine (Baltimore)
Miao Y, Li Q, Chen J, Liu Z.
europepmc   +1 more source

Thrombectomy in acute myocardial infarction: Current evidence, challenges, and emerging technologies. [PDF]

World J Clin Cases
Abdeldayem T, Memon S, Omari M, Egred M, Bawamia B, Farag M, Alkhalil M.   +6 more
europepmc   +1 more source

Quantitative Flow Cytometry-Medical Applications with a Focus on Blood Platelets. [PDF]

Int J Mol Sci
Poncelet P, Lecompte T, Bauters A, Mullier F.   +3 more
europepmc   +1 more source